Ziosoft Receives FDA Clearance for its MR Cardiac Function Analysis Application

Share Article

Cardiac MR module expands the clinical value of the Ziostation® Thin-Client Advanced Visualization System

Ziosoft's MR cardiac function analysis application illustrating the software's workflow oriented design, which allows physicians to easily determine important quantitative results.

Ziosoft is proud to offer a cardiac MR functional module which provides physicians with another option for assessing cardiac function,

Ziosoft®, Inc., http://www.ziosoftinc.com a leader in advanced visualization and analysis software for medical imaging, today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its magnetic resonance (MR) cardiac function analysis application for use with the Ziostation® thin-client system.

The MR cardiac function analysis application is used by physicians to evaluate the structures and function of the heart in the initial screening and subsequent management of coronary disease patients. Ziosoft's MR cardiac function application provides physicians with the unique capability to extract left ventricle myocardial contours from Ziosoft's automatic interpolation algorithm to obtain highly accurate results.

In addition to the standard functional assessment calculations such as ejection fraction, peak filling rate (PFR) and peak ejection rate (PER), automatic calculation of myocardial mass is also generated with the Ziosoft application. The software provides the capability to automatically produce "bull's eye" representations as well as a time volume graph to aid in the patient evaluation. Ziosoft's application has the ability to display different sequences in one view, allowing clinicians to scroll between sequences and positions simultaneously. This exclusive feature provides an intuitive method of displaying patient information for more proficient image interpretation. The MR cardiac function application can be accessed throughout the enterprise on the Ziostation thin-client system to provide physicians with improved efficiency and real-time collaboration when assessing results from an MR study.

MR has advanced over the years to provide outstanding image quality while maintaining a non-ionizing means of image acquisition. "Ziosoft is proud to offer a cardiac MR functional module which provides physicians with another option for assessing cardiac function, "said Mark Koeniguer, Ziosoft's chief operating officer. "This latest application offers significant enhancements to our cardiac offering and provides physicians with state of the art tools to improve patient outcomes."

About Ziosoft Inc.
Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is a leading independent advanced visualization company with over 1800 installed systems in over 800 sites worldwide. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium, and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com.

Ziosoft and Ziostation are registered trademarks of Ziosoft Inc.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Betsy Davis
650 413-1374
Email >
Visit website